- Home
- DGLY vs SBFM Comparison
DGLY vs SBFM Comparison
Compare DGLY & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- SBFM
- Stock Information
- Founded
- DGLY N/A
- SBFM 2006
- Country
- DGLY United States
- SBFM United States
- Employees
- DGLY N/A
- SBFM N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- SBFM Health Care
- Exchange
- DGLY Nasdaq
- SBFM Nasdaq
- Market Cap
- DGLY 4.1M
- SBFM 6.7M
- IPO Year
- DGLY N/A
- SBFM N/A
- Fundamental
- Price
- DGLY $2.17
- SBFM $1.51
- Analyst Decision
- DGLY
- SBFM Strong Buy
- Analyst Count
- DGLY 0
- SBFM 1
- Target Price
- DGLY N/A
- SBFM $15.00
- AVG Volume (30 Days)
- DGLY 100.9K
- SBFM 192.4K
- Earning Date
- DGLY 08-15-2025
- SBFM 08-15-2025
- Dividend Yield
- DGLY N/A
- SBFM N/A
- EPS Growth
- DGLY N/A
- SBFM N/A
- EPS
- DGLY N/A
- SBFM N/A
- Revenue
- DGLY $18,596,715.00
- SBFM $36,234,578.00
- Revenue This Year
- DGLY N/A
- SBFM $192.48
- Revenue Next Year
- DGLY N/A
- SBFM N/A
- P/E Ratio
- DGLY N/A
- SBFM N/A
- Revenue Growth
- DGLY N/A
- SBFM 35.51
- 52 Week Low
- DGLY $1.93
- SBFM $1.17
- 52 Week High
- DGLY $265.00
- SBFM $6.99
- Technical
- Relative Strength Index (RSI)
- DGLY 25.65
- SBFM 49.86
- Support Level
- DGLY $2.19
- SBFM $1.43
- Resistance Level
- DGLY $2.32
- SBFM $1.61
- Average True Range (ATR)
- DGLY 0.12
- SBFM 0.12
- MACD
- DGLY 0.90
- SBFM 0.00
- Stochastic Oscillator
- DGLY 25.00
- SBFM 32.78
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.